Novavax, Inc. - Common Stock (NVAX)

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or “the Company”) (NASDAQNVAX). Investors who purchased Novavax securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NVAX.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or “the Company”) (NASDAQNVAX). Investors who purchased Novavax securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NVAX.

EQNX::TICKER_START (NASDAQSBFM),NASDAQ:NVAXNASDAQNVAX)(NASDAQ:RGNXNASDAQRGNX,(NASDAQ:BNTXNASDAQ),(NYSE:ABBVABBV) EQNX::TICKER_END

Novavax, Inc. (NASDAQNVAX) is one of today’s top gainers. The company’s shares are currently up 24.23% on the day to $8.98.

PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for therapies and treatments. A report from Transparency Market Research said that: “the emergence of new variants of coronavirus will boost COVID-19 therapeutics market growth. Demand for drugs that can effectively treat new strains of the virus is likely to be significantly high, as these new variants may be less susceptible to existing therapeutics. This is projected to boost the COVID-19 therapeutics market size, as pharmaceutical companies race to develop new drugs and treatments to address these new variants. Even after the pandemic is under control, there would still be a need for treatments and therapies to help those who have been affected by the virus, including those with long-term effects. This is anticipated to continue to drive COVID-19 therapeutics market demand. Additionally, emergence of new variants of the virus and the possibility of future outbreaks are anticipated to prompt governments and private organizations to be better prepared for future pandemics.” Active companies in the biotech industry this week include Sunshine Biopharma Inc. (NASDAQSBFM), Novavax, Inc. NASDAQ: NVAXNASDAQNVAX)(NASDAQ: RGNXNASDAQRGNX, BIONTECH SE (NASDAQ: BNTXNASDAQ), Abbvie (NYSE: ABBVABBV).

Biotechnology company Moderna Inc. (NASDAQMRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release.

Novavax Inc. (NASDAQNVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases.

On June 25, Intelligent Bio Solutions Inc. (NASDAQINBS) trending upwards in after-hours trading. The medical technology company, known for its intelligent, fast, and non-invasive testing solutions, made a significant announcement on June 20. Intelligent Bio Solutions revealed it had successfully signed two major customers in the UK's warehouse and logistics sector over the past three months. These two companies boast a combined workforce of over 15,000 employees across 70 locations.

GameStop Corp (NYSEGME) announced it had raised approximately $2.14 billion through a share sale, positioning the company for potential mergers and acquisitions. The capital infusion opens up various strategic opportunities that GameStop hinted might be forthcoming. Investor confidence surged as stock influencer Keith Gill, known as "Roaring Kitty," indicated he maintained a significant stake in GameStop. A spike in trading of short-dated GameStop options on Wednesday led some market participants to speculate that Gill may have sold some of his recently-disclosed option’s position in the company.

As meme stock mania continues, stocks with high short interest like Novavax, Upstart, C3.ai, and Comstock Resources may attract renewed interest.

In recent days, a surge of interest has spotlighted several key companies, capturing significant attention from investors. This feature delves into a detailed analysis of five standout firms, offering insights that could prove crucial for investors in the near future.

Market activity has picked up, with meme stocks outperforming broader market trends. Interest in these stocks has surged, largely driven by the online influencer known as "Roaring Kitty," who ignited a social media frenzy on Reddit Inc. (NYSERDDT) involving GameStop NYSE: GMENYSEGME)(NYSE: GMENYSEGME, AMC Entertainment (NYSE: AMCNYSE), Dyadic International Inc. (NASDAQ: DYAIDYAI), Novavax Inc. (NASDAQNVAX), and Peraso Inc. NASDAQ: PRSONASDAQPRSO)

Novavax's future hinges on its ability to translate recent stock market momentum into sustained financial performance.

Dyadic International Inc. (NASDAQDYAI), a biotechnology company specializing in large-scale protein manufacturing for vaccines, therapeutics, and non-pharmaceutical applications like biofuels and next-generation foods, ( read entire press release ) reached a new 52-week high of $2.42 on Thursday, May 30, 2024. This achievement marks a significant 103% increase from its 52-week low of $1.19. The stock's 50-day moving average stands at $1.6631, while the 200-day moving average is $1.6521, culminating in a "Golden Cross" on May 30, 2024. Furthermore, the stock demonstrated a "Jack in the Box" pattern with a Bullish Swing Set-Up on Friday, May 31, 2024. Read the full press release for more details.

Peraso Inc. (NASDAQPRSO) Utilizing mmWave Wi-Fi, Peraso’s phased array antenna technology enables PSNRD’s latest 60GHz WLAN solution to deliver high-speed, low-latency wireless communication, comparable to wired LAN, over distances extending hundreds of meters. This innovative solution is designed for effortless installation and operation, benefiting from the interference-free and unlicensed use of the 60 GHz band alongside narrow beam directional antenna control. These advancements could represent a significant paradigm shift in the wireless communication industry.

The coronavirus pandemic, a vivid memory for many, halted the world and reshaped lives. Despite a return to normalcy, the threat of pandemics persists, with the H5N1 avian flu (bird flu) emerging as a potential danger. Health experts caution that a bird flu outbreak could be 100 times more severe than COVID-19.

Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi

Keith Gill, aka RoaringKitty, resurfaces on Twitter, triggering a surge in GameStop and AMC Entertainment shares amid remarkable trading volume.

Highlights Novavax’s Massive Untapped Value That it Believes is Being Hindered by an Overly Conservative Board and Management That Clings to Failed Strategies and Have Undermined Stockholder Value

After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report

Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price

Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI.

Stocks exhibiting significant short interest frequently experience substantial price surges due to a short squeeze, making it advisable for investors to monitor such stocks. Here's a brief overview of five such stocks.

Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.

The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with